These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 7869472

  • 1. p53 mutations and prognosis in bladder tumors.
    Uchida T, Wada C, Ishida H, Wang C, Egawa S, Yokoyama E, Kameya T, Koshiba K.
    J Urol; 1995 Apr; 153(4):1097-104. PubMed ID: 7869472
    [Abstract] [Full Text] [Related]

  • 2. Frequent association of p53 gene mutation in invasive bladder cancer.
    Fujimoto K, Yamada Y, Okajima E, Kakizoe T, Sasaki H, Sugimura T, Terada M.
    Cancer Res; 1992 Mar 15; 52(6):1393-8. PubMed ID: 1540947
    [Abstract] [Full Text] [Related]

  • 3. Role of chromosome 9 in human bladder cancer.
    Miyao N, Tsai YC, Lerner SP, Olumi AF, Spruck CH, Gonzalez-Zulueta M, Nichols PW, Skinner DG, Jones PA.
    Cancer Res; 1993 Sep 01; 53(17):4066-70. PubMed ID: 8358736
    [Abstract] [Full Text] [Related]

  • 4. Prognostic implications of p53 gene mutations in bladder tumors.
    Lorenzo-Romero JG, Salinas-Sánchez AS, Giménez-Bachs JM, Sánchez-Sánchez F, Escribano-Martínez J, Segura-Martín M, Hernandez-Millán IR, Virseda-Rodríguez JA.
    J Urol; 2003 Feb 01; 169(2):492-9. PubMed ID: 12544295
    [Abstract] [Full Text] [Related]

  • 5. Molecular genetic alterations of chromosome 17 and p53 nuclear overexpression in human bladder cancer.
    Dalbagni G, Presti JC, Reuter VE, Zhang ZF, Sarkis AS, Fair WR, Cordon-Cardo C.
    Diagn Mol Pathol; 1993 Mar 01; 2(1):4-13. PubMed ID: 7904525
    [Abstract] [Full Text] [Related]

  • 6. Influence of cigarette smoking and schistosomiasis on p53 gene mutation in urothelial cancer.
    Habuchi T, Takahashi R, Yamada H, Ogawa O, Kakehi Y, Ogura K, Hamazaki S, Toguchida J, Ishizaki K, Fujita J.
    Cancer Res; 1993 Aug 15; 53(16):3795-9. PubMed ID: 8339293
    [Abstract] [Full Text] [Related]

  • 7. Implications of p53 gene mutations on patient survival in transitional cell carcinoma of the bladder: a long-term study.
    Salinas-Sánchez AS, Lorenzo-Romero JG, Giménez-Bachs JM, Sánchez-Sánchez F, Donate-Moreno MJ, Rubio-Del-Campo A, Hernández-Millán IR, Segura-Martín M, Atienzar-Tobarra M, Escribano-Martínez J.
    Urol Oncol; 2008 Aug 15; 26(6):620-6. PubMed ID: 18367096
    [Abstract] [Full Text] [Related]

  • 8. p53 Gene mutations in superficial bladder cancer.
    Lorenzo Romero JG, Salinas Sánchez AS, Giménez Bachs JM, Sánchez Sánchez F, Escribano Martínez J, Hernández Millán IR, Segura Martín M, Virseda Rodríguez JA.
    Urol Int; 2004 Aug 15; 73(3):212-8. PubMed ID: 15539839
    [Abstract] [Full Text] [Related]

  • 9. Influence of cigarette smoking on P53 gene mutations in bladder carcinomas.
    Bernardini S, Adessi GL, Chezy E, Billerey C, Carbillet JP, Bittard H.
    Anticancer Res; 2001 Aug 15; 21(4B):3001-4. PubMed ID: 11712801
    [Abstract] [Full Text] [Related]

  • 10. A molecular and epidemiological study on bladder cancer: p53 mutations, tobacco smoking, and occupational exposure to asbestos.
    Kannio A, Ridanpää M, Koskinen H, Partanen T, Anttila S, Collan Y, Hietanen E, Vainio H, Husgafvel-Pursiainen K.
    Cancer Epidemiol Biomarkers Prev; 1996 Jan 15; 5(1):33-9. PubMed ID: 8770464
    [Abstract] [Full Text] [Related]

  • 11. Analyses of p53 gene mutations in primary human bladder cancer.
    Miyamoto H, Kubota Y, Shuin T, Torigoe S, Hosaka M, Iwasaki Y, Danenberg K, Danenberg PV.
    Oncol Res; 1993 Jan 15; 5(6-7):245-9. PubMed ID: 8123944
    [Abstract] [Full Text] [Related]

  • 12. p53 mutations in human malignant gliomas: comparison of loss of heterozygosity with mutation frequency.
    Frankel RH, Bayona W, Koslow M, Newcomb EW.
    Cancer Res; 1992 Mar 15; 52(6):1427-33. PubMed ID: 1347252
    [Abstract] [Full Text] [Related]

  • 13. [The study of p53 gene mutation in human bladder cancer].
    Ding Q, Zhang Y, Sun X.
    Zhonghua Wai Ke Za Zhi; 1995 Nov 15; 33(11):684-6. PubMed ID: 8731915
    [Abstract] [Full Text] [Related]

  • 14. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer.
    Huang C, Taki T, Adachi M, Konishi T, Higashiyama M, Miyake M.
    Oncogene; 1998 May 14; 16(19):2469-77. PubMed ID: 9627113
    [Abstract] [Full Text] [Related]

  • 15. p53 gene mutation in recurrent superficial bladder cancer.
    Yoshimura I, Kudoh J, Saito S, Tazaki H, Shimizu N.
    J Urol; 1995 May 14; 153(5):1711-5. PubMed ID: 7715016
    [Abstract] [Full Text] [Related]

  • 16. Two molecular pathways to transitional cell carcinoma of the bladder.
    Spruck CH, Ohneseit PF, Gonzalez-Zulueta M, Esrig D, Miyao N, Tsai YC, Lerner SP, Schmütte C, Yang AS, Cote R.
    Cancer Res; 1994 Feb 01; 54(3):784-8. PubMed ID: 8306342
    [Abstract] [Full Text] [Related]

  • 17. Chromosome 17p deletions and p53 mutations in renal cell carcinoma.
    Reiter RE, Anglard P, Liu S, Gnarra JR, Linehan WM.
    Cancer Res; 1993 Jul 01; 53(13):3092-7. PubMed ID: 8319216
    [Abstract] [Full Text] [Related]

  • 18. Loss of heterozygosity at the p53, RB, DCC and APC tumor suppressor gene loci in human bladder cancer.
    Miyamoto H, Shuin T, Ikeda I, Hosaka M, Kubota Y.
    J Urol; 1996 Apr 01; 155(4):1444-7. PubMed ID: 8632608
    [Abstract] [Full Text] [Related]

  • 19. TP53 alterations as a potential diagnostic marker in superficial bladder carcinoma and in patients serum, plasma and urine samples.
    Dahse R, Utting M, Werner W, Schimmel B, Claussen U, Junker K.
    Int J Oncol; 2002 Jan 01; 20(1):107-15. PubMed ID: 11743649
    [Abstract] [Full Text] [Related]

  • 20. Loss of 17p, mutation of the p53 gene, and overexpression of p53 protein in esophageal squamous cell carcinomas.
    Wagata T, Shibagaki I, Imamura M, Shimada Y, Toguchida J, Yandell DW, Ikenaga M, Tobe T, Ishizaki K.
    Cancer Res; 1993 Feb 15; 53(4):846-50. PubMed ID: 8094033
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.